Success of the placement with professional investors, historical supporters of the Company, for an amount of €1.9M.Strong participation of retail investors via the PrimaryBid platform with an offer allocated to €0.4M[1].Funds raised to finance the Marketing Authorisation Applications of Sarconeos (BIO101) for the treatment of severe forms of COVID-19.PARIS…
Read More
